Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baohe Jujuepian (Baohe chewable tablets) is an approved traditional Chinese medicine (TCM) developed and manufactured by Bangmin Pharmaceutical. Formulated as an oral chewable tablet, it is based on the classic TCM formula Baohe Wan, which contains Crataegi Fructus (shanzha), Massa Medicata Fermentata (shenqu), Pinelliae Rhizoma (banxia), Poria (fuling), Citri Reticulatae Pericarpium (chenpi), Forsythiae Fructus (lianqiao), Raphani Semen (laifuzi), and Hordei Fructus Germinatus (maiya). Baohe Jujuepian is indicated for promoting digestion, resolving food retention, and harmonizing the stomach, and is commonly used to treat dyspepsia, abdominal distension, acid regurgitation, and loss of appetite.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baohe Jujuepian.